查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086248

精準醫療市場：2026-2032年全球市場預測（按產品類型、生物標記類型、給藥途徑、應用和最終用戶分類）

Precision Medicine Market by Product Type, Biomarker Type, Route of Administration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，精準醫療市場規模將達到 3,249.2 億美元，複合年成長率為 13.34%。

主要市場統計數據
基準年 2025 1352.2億美元
預計年份：2026年 1526.8億美元
預測年份 2032 3249.2億美元
複合年成長率 (%) 13.34%

精準醫療市場概覽

精準醫療正在重新定義醫療保健，它根據每位患者獨特的生物學、環境和生活方式特徵，量身定做預防、診斷和治療方案。這個市場正從基於人群的廣泛醫療模式，發展到基於生物標記的療法、基因組檢測、伴隨診斷、藥物基因體學影像學和數據驅動的臨床決策支援。

精準醫療的變革

精準醫療的格局正從獨立的基因檢測轉向整合多組體學、真實世界數據、電子健康記錄、影像學、穿戴式裝置數據和長期病患監測。次世代定序、液態生物檢體、分散式臨床試驗和伴隨診斷正在加速實現更早期的檢測和更有針對性的治療方案。

人工智慧的累積影響

人工智慧正在精準醫療領域創造累積價值，它能夠幫助研究人員從基因組學、轉錄組學、蛋白質組學、病理學、放射學、保險理賠數據和臨床記錄中發現模式。當與高品質的臨床證據檢驗後，人工智慧模型可以輔助解讀突變、對患者進行分層、發現藥物標靶、匹配臨床試驗、預測不利事件以及預測治療反應。

關鍵區域洞察

北美憑藉其成熟的基因組學基礎設施、經FDA批准的舉措評估途徑、對生物製藥行業的強勁投資以及美國和加拿大大規模的研究網路，繼續引領精準醫療領域。歐洲則透過跨境基因組學計畫、國家定序計畫、健全的學術和醫療保健體係以及基於GDPR的數據管治，穩步推動精準醫療的發展。歐盟透過歐洲健康數據空間和百萬基因組框架等舉措，支持健康數據的互通性。

關鍵群體特定見解

在東協，新加坡、泰國、馬來西亞、印尼、越南和菲律賓正在加強基因組學、數位健康、檢查室認證和臨床研究方面的能力建設，各國的發展成熟度不盡相同，並逐漸成為精準醫療實際發展的中心。海灣合作理事會（GCC）地區的特點是：沙烏地阿拉伯、阿拉伯聯合大公國、卡達及其周邊市場推行政府主導的基因組學計畫、大力投資醫院建設、制定國家人工智慧戰略和國家衛生舉措。

主要國家的概況

美國憑藉國立衛生研究院 (NIH) 資助的研究、美國食品藥物管理局 (FDA) 的生物標記指南、大學附屬醫療中心、商業性基因組檢測以及強大的生物製藥研發管線，在該領域處於領先地位。加拿大正透過省級基因組計畫、全國性研究食品藥物管理局和人口健康數據資產推動精準醫療的發展。同時，墨西哥正透過癌症診斷、檢查室現代化以及公私合營進行臨床研究來擴大醫療保健的覆蓋範圍。巴西在拉丁美洲的基因組研究、癌症治療創新和罕見疾病研究方面發揮核心作用。

為行業領導者提供的實用建議

產業領導者應優先考慮臨床效用，而非僅僅採用技術。成功的精準醫療策略需要檢驗的生物標記、可互通的數據架構、品管的檢測、醫生培訓、向保險公司提供的證據，以及在不同人群中可衡量的患者療效。

調查方法

本執行摘要基於經過驗證的二手研究和系統性的行業分析，所用資訊來源包括公開的監管文件、臨床試驗註冊資訊、政府基因組計劃的最新進展、同行檢驗文獻、衛生機構出版刊物、政策文件以及經認證的公共醫療保健資料集。參考資料來源包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、美國國立衛生研究院 (NIH)、歐盟委員會、各國基因組計畫、臨床指南庫以及公開的精準醫療政策文件。

結論

精準醫療正從小眾創新領域轉向以基因組學、人工智慧、伴隨診斷、真實世界數據以及日益互聯的醫療數據生態系統為驅動的核心醫療模式。當科學檢驗、監管信心、明確的報銷機制、與臨床工作流程的整合以及患者公平獲取醫療服務這四者齊頭並進時，精準醫療將迎來最大的發展機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 精準醫療市場：依產品類型分類

  • 診斷
    • 伴隨診斷
    • 基因檢測
    • 液態生物檢體
    • 分子診斷
    • 即時檢測
  • 軟體和數據分析
  • 治療
    • 細胞療法
    • 基因治療
    • 免疫療法
    • 蛋白質替代療法
    • 基於RNA的療法
    • 標靶治療

第8章 精準醫療市場：依生物標記類型分類

  • 基因生物標記
  • 蛋白質體學生物標記
  • 代謝體學物標誌物
  • 表觀遺傳生物標記

第9章 精準醫療市場：依給藥途徑分類

  • 口服
  • 注射藥物
  • 靜脈
  • 皮下

第10章 精準醫療市場：依應用領域分類

  • 自體免疫疾病
  • 心臟病學
  • 感染疾病
  • 神經病學
  • 腫瘤學
  • 罕見疾病和遺傳疾病
  • 呼吸系統疾病

第11章 精準醫療市場：依最終用戶分類

  • 生物製藥和生物技術公司
  • 診斷檢查室
  • 醫院和診所
  • 研究機構

第12章 精準醫療市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 精準醫療市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 精準醫療市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AbbVie Inc.
  • Amgen Inc.
  • Aranscia, LLC
  • AstraZeneca PLC
  • biocrates life sciences ag
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Caris Life Sciences
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Guardant Health, Inc.
  • healthOme, Inc.
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Merck KGaA
  • N-Power Medicine, Inc.
  • Natera Inc.
  • NeoGenomics, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Precision Medicine Group, LLC
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Strata Oncology, Inc.
  • Tempus AI, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • ZS Associates, Inc.
Product Code: MRR-030EE48515D0

The Precision Medicine Market is projected to grow by USD 324.92 billion at a CAGR of 13.34% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 135.22 billion
Estimated Year [2026] USD 152.68 billion
Forecast Year [2032] USD 324.92 billion
CAGR (%) 13.34%

Precision Medicine Market Introduction

Precision medicine is redefining healthcare by matching prevention, diagnosis, and treatment to the biological, environmental, and lifestyle characteristics of each patient. The market is advancing from broad population-based care toward biomarker-driven therapies, genomic testing, companion diagnostics, pharmacogenomics, molecular imaging, and data-enabled clinical decision support.

Adoption is strongest in oncology, rare diseases, immunology, cardiology, neurology, and infectious disease management, where validated biomarkers increasingly guide therapy selection and monitoring. Public programs such as NIH All of Us, the UK 100,000 Genomes Project, Genome India, national genome initiatives in the Gulf, and the European 1+ Million Genomes framework demonstrate that precision medicine is now a strategic priority for health systems, life sciences companies, diagnostics developers, payers, and digital health providers.

Transformative Shifts in Precision Medicine

The precision medicine landscape is shifting from isolated genetic tests to integrated multi-omics, real-world evidence, electronic health records, imaging, wearable data, and longitudinal patient monitoring. Next-generation sequencing, liquid biopsy, decentralized clinical trials, and companion diagnostics are accelerating earlier detection and more targeted treatment pathways.

Regulatory and reimbursement models are also evolving. Agencies such as the FDA and EMA support biomarker-based drug development, while payers increasingly require clinical utility, health economic evidence, and equitable access strategies. Industry leaders are responding with cloud-based data platforms, privacy-preserving analytics, adaptive trial designs, and partnerships among biopharma, hospitals, laboratories, academic centers, and technology providers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across precision medicine by helping researchers detect patterns in genomics, transcriptomics, proteomics, pathology, radiology, claims data, and clinical notes. AI-enabled models support variant interpretation, patient stratification, drug target discovery, trial matching, adverse event prediction, and treatment response forecasting when validated against high-quality clinical evidence.

The greatest impact is emerging where AI is combined with curated datasets, transparent model governance, and clinician oversight. Federated learning, synthetic data, and privacy-enhancing technologies are helping organizations collaborate without exposing sensitive patient information. However, successful deployment depends on bias testing, regulatory alignment, explainability, cybersecurity, and continuous monitoring to ensure that AI improves precision medicine outcomes rather than amplifying health disparities.

Key Regional Insights

North America remains a leading precision medicine region due to mature genomics infrastructure, FDA-recognized biomarker pathways, strong biopharma investment, and large research networks in the United States and Canada. Europe is advancing through cross-border genomics initiatives, national sequencing programs, strong academic medicine, and GDPR-driven data governance, with the European Union supporting health data interoperability through initiatives such as the European Health Data Space and the 1+ Million Genomes framework.

Asia-Pacific is scaling quickly as China, Japan, India, South Korea, Australia, and ASEAN markets expand genomic medicine, oncology diagnostics, population health programs, and digital hospital infrastructure. Latin America, led by Brazil and Mexico, is building capacity through cancer genomics, academic networks, biobanking, and private laboratory expansion. The Middle East is accelerating through national genome programs in GCC countries, precision oncology centers, and government-led digital health investment, while Africa is gaining momentum through infectious disease genomics, sickle cell research, newborn screening, and partnerships focused on improving African representation in global genomic datasets.

Key Group Insights

ASEAN is becoming a practical growth corridor for precision medicine as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines strengthen genomics, digital health, laboratory accreditation, and clinical research capabilities at different maturity levels. The GCC is distinguished by government-backed genome programs, strong hospital investment, national AI strategies, and population health initiatives in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets.

The European Union provides scale through data protection standards, cross-border biomedical research, regulatory alignment, and the European Health Data Space agenda. BRICS countries offer large, genetically diverse populations, expanding sequencing capacity, and growing biomanufacturing capabilities, while the G7 leads in regulatory science, advanced diagnostics, AI governance, health data standards, and biopharma innovation. NATO countries are also relevant through health security, bio-surveillance, cybersecurity, pandemic preparedness, and resilient medical supply chains that support precision medicine infrastructure.

Key Country Insights

The United States leads through NIH-funded research, FDA biomarker guidance, academic medical centers, commercial genomic testing, and strong biopharma pipelines. Canada is advancing precision health through provincial genomics programs, pan-Canadian research networks, and population health data assets, while Mexico is expanding access through oncology diagnostics, laboratory modernization, and public-private clinical collaborations. Brazil is the Latin American anchor for genomic research, cancer care innovation, and rare disease investigation.

In Europe, the United Kingdom benefits from NHS-linked genomics and national sequencing experience, Germany from precision oncology, engineering depth, and clinical research strength, France from national genomic medicine planning and cancer research networks, Italy and Spain from strong clinical networks and regional genomic programs, and Russia from domestic biomedical research despite access and collaboration constraints. In Asia-Pacific, China is scaling sequencing, oncology innovation, and hospital-based genomics; India is expanding Genome India, biobank development, and cost-efficient diagnostics; Japan is strong in regenerative medicine, oncology, and pharmacogenomics; Australia has leading genomic medicine programs and strong rare disease initiatives; and South Korea combines hospital digitization, sequencing, AI-enabled healthcare, and biopharma investment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical utility, not technology adoption alone. Successful precision medicine strategies require validated biomarkers, interoperable data architecture, quality-controlled testing, physician education, payer evidence, and measurable patient outcomes across diverse populations.

Organizations should build partnerships across biopharma, diagnostics, providers, payers, regulators, and technology specialists. Near-term priorities include investing in AI-ready data governance, expanding companion diagnostic access, designing inclusive clinical trials, strengthening cybersecurity, demonstrating cost-effectiveness, and aligning product development with regulatory expectations for biomarker evidence and real-world performance.

Research Methodology

This executive summary is developed from verified secondary research and structured industry analysis using public regulatory resources, clinical trial registries, government genome program updates, peer-reviewed literature, health agency publications, policy documents, and recognized public healthcare datasets. Sources considered include FDA, EMA, NIH, the European Commission, national genomics programs, clinical guideline repositories, and publicly available precision medicine policy documents.

Insights are triangulated across technology adoption, regulatory direction, clinical use cases, investment activity, regional infrastructure, reimbursement readiness, and health data governance. The methodology emphasizes data reliability, source credibility, recency, and cross-validation to ensure that conclusions reflect measurable precision medicine developments rather than speculative claims.

Conclusion

Precision medicine is moving from an innovation niche to a core healthcare model supported by genomics, AI, companion diagnostics, real-world evidence, and increasingly connected health data ecosystems. The strongest opportunities will emerge where scientific validation, regulatory confidence, reimbursement clarity, clinical workflow integration, and equitable patient access converge.

For industry stakeholders, the next phase will be defined by scalable clinical implementation. Organizations that combine high-quality data, validated biomarkers, responsible AI, inclusive research, and cross-sector partnerships will be best positioned to strengthen adoption across the global precision medicine landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Precision Medicine Market, by Product Type

  • 7.1. Diagnostics
    • 7.1.1. Companion Diagnostics
    • 7.1.2. Genetic Testing
    • 7.1.3. Liquid Biopsy
    • 7.1.4. Molecular Diagnostics
    • 7.1.5. Point-of-Care Testing
  • 7.2. Software & Data Analytics
  • 7.3. Therapeutics
    • 7.3.1. Cell Therapy
    • 7.3.2. Gene Therapy
    • 7.3.3. Immunotherapy
    • 7.3.4. Protein Replacement Therapy
    • 7.3.5. RNA-Based Therapy
    • 7.3.6. Targeted Therapy

8. Precision Medicine Market, by Biomarker Type

  • 8.1. Genomic Biomarkers
  • 8.2. Proteomic Biomarkers
  • 8.3. Metabolomic Biomarkers
  • 8.4. Epigenetic Biomarkers

9. Precision Medicine Market, by Route of Administration

  • 9.1. Oral
  • 9.2. Injectable
  • 9.3. Intravenous
  • 9.4. Subcutaneous

10. Precision Medicine Market, by Application

  • 10.1. Autoimmune Diseases
  • 10.2. Cardiology
  • 10.3. Infectious Diseases
  • 10.4. Neurology
  • 10.5. Oncology
  • 10.6. Rare & Genetic Disorders
  • 10.7. Respiratory Diseases

11. Precision Medicine Market, by End User

  • 11.1. Biopharmaceutical & Biotechnology Companies
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics
  • 11.4. Research Institutes

12. Precision Medicine Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Precision Medicine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Precision Medicine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AbbVie Inc.
  • 16.2. Amgen Inc.
  • 16.3. Aranscia, LLC
  • 16.4. AstraZeneca PLC
  • 16.5. biocrates life sciences ag
  • 16.6. bioMerieux S.A.
  • 16.7. Bristol-Myers Squibb Company
  • 16.8. Caris Life Sciences
  • 16.9. Exact Sciences Corporation
  • 16.10. F. Hoffmann-La Roche AG
  • 16.11. Gilead Sciences, Inc.
  • 16.12. Guardant Health, Inc.
  • 16.13. healthOme, Inc.
  • 16.14. Hitachi High-Tech Corporation
  • 16.15. Illumina, Inc.
  • 16.16. Johnson & Johnson
  • 16.17. Laboratory Corporation of America Holdings
  • 16.18. Medtronic PLC
  • 16.19. Merck KGaA
  • 16.20. N-Power Medicine, Inc.
  • 16.21. Natera Inc.
  • 16.22. NeoGenomics, Inc.
  • 16.23. Novartis AG
  • 16.24. Pfizer, Inc.
  • 16.25. Precision Medicine Group, LLC
  • 16.26. QIAGEN N.V.
  • 16.27. Quest Diagnostics Incorporated
  • 16.28. Sanofi SA
  • 16.29. Strata Oncology, Inc.
  • 16.30. Tempus AI, Inc.
  • 16.31. Teva Pharmaceutical Industries Ltd.
  • 16.32. Thermo Fisher Scientific Inc.
  • 16.33. ZS Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PRECISION MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PRECISION MEDICINE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PRECISION MEDICINE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PRECISION MEDICINE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIQUID BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SOFTWARE & DATA ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SOFTWARE & DATA ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SOFTWARE & DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROTEIN REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROTEIN REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROTEIN REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RNA-BASED THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RNA-BASED THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RNA-BASED THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TARGETED THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TARGETED THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TARGETED THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GENOMIC BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GENOMIC BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GENOMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROTEOMIC BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PROTEOMIC BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROTEOMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL METABOLOMIC BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL METABOLOMIC BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL METABOLOMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EPIGENETIC BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EPIGENETIC BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EPIGENETIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RARE & GENETIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RARE & GENETIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RARE & GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. GCC PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GCC PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. G7 PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 191. G7 PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 192. G7 PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. G7 PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. G7 PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. NATO PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. NATO PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 200. NATO PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 202. NATO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 216. CANADA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 217. CANADA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. CANADA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 219. CANADA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. CANADA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. MEXICO PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 227. MEXICO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. MEXICO PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GERMANY PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. GERMANY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. FRANCE PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. FRANCE PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. FRANCE PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 256. FRANCE PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. RUSSIA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. RUSSIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. RUSSIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 264. RUSSIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 265. RUSSIA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. ITALY PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. ITALY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. ITALY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 272. ITALY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 273. ITALY PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ITALY PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 275. ITALY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. SPAIN PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. SPAIN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. SPAIN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 280. SPAIN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 281. SPAIN PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. SPAIN PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 283. SPAIN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. SPAIN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. INDIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. INDIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 297. INDIA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. INDIA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 299. INDIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. INDIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. JAPAN PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. JAPAN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. JAPAN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 304. JAPAN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 305. JAPAN PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. JAPAN PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 307. JAPAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. JAPAN PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 313. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 315. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 323. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)